157 related articles for article (PubMed ID: 10365804)
1. HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
Kakizaki S; Takagi H; Murakami M; Takayama H; Mori M
J Hepatol; 1999 May; 30(5):794-800. PubMed ID: 10365804
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmune thyroid disease induced by interferon therapy].
Murakami M; Kakizaki S; Takayama H; Takagi H; Mori M
Nihon Rinsho; 1999 Aug; 57(8):1779-83. PubMed ID: 10483250
[TBL] [Abstract][Full Text] [Related]
3. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C.
Doi F; Kakizaki S; Takagi H; Murakami M; Sohara N; Otsuka T; Abe T; Mori M
Liver Int; 2005 Apr; 25(2):242-6. PubMed ID: 15780045
[TBL] [Abstract][Full Text] [Related]
5. The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
Krupińska J; Wawrzynowicz-Syczewska M; Urbanowicz W; Pobłocki J; Syrenicz A
Endokrynol Pol; 2011; 62(6):517-22. PubMed ID: 22144218
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
7. Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis.
Labbadia G; Martocchia A; Mammarella A; Paoletti V; Rocco A; Benvenuto R; Antonella P; Rosaria D; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2005 Apr; 26(2):109-12. PubMed ID: 15855880
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
Ettinger OA; Nikitin IG; Storozhakov GI
Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
[No Abstract] [Full Text] [Related]
9. HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin.
Tseng CW; Hsieh YH; Chang CK; Lai NS; Hung TH; Wu SF; Tseng KC
Tissue Antigens; 2012 Nov; 80(5):424-30. PubMed ID: 22931407
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations.
Ward DL; Bing-You RG
Endocr Pract; 2001; 7(1):52-8. PubMed ID: 11250770
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy.
Antonelli A; Ferri C; Fallahi P
Nat Rev Gastroenterol Hepatol; 2009 Nov; 6(11):633-5. PubMed ID: 19881515
[No Abstract] [Full Text] [Related]
13. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
14. Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C.
Morisco F; Mazziotti G; Rotondi M; Tuccillo C; Iasevoli P; Del Buono A; Sorvillo F; Amato G; Marmo R; Caporaso N; Carella C
Dig Liver Dis; 2001 Apr; 33(3):247-53. PubMed ID: 11407670
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
Koh LK; Greenspan FS; Yeo PP
Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis B with type I diabetes mellitus and autoimmune thyroiditis development during interferon alpha therapy.
Kose S; Gozaydin A; Akkoclu G; Ece G
J Infect Dev Ctries; 2012 Apr; 6(4):364-8. PubMed ID: 22505448
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection.
Chong VH
Singapore Med J; 2011 Feb; 52(2):e20-2. PubMed ID: 21373724
[TBL] [Abstract][Full Text] [Related]
18. Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study.
Mazziotti G; Sorvillo F; Stornaiuolo G; Rotondi M; Morisco F; Ruberto M; Cioffi M; Amato G; Caporaso N; Gaeta GB; Carella C
J Endocrinol Invest; 2002; 25(7):624-30. PubMed ID: 12150338
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto's disease during interferon-alpha therapy in a patient with pre-treatment negative anti-thyroid autoantibodies and with the specific genetic susceptibility to the thyroid disease.
Martocchia A; Labbadia G; Paoletti V; Gargano S; Grossi A; Trabace S; Musca A; Falaschi P
Neuro Endocrinol Lett; 2001; 22(1):49-52. PubMed ID: 11335880
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
